Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Reichert, Tom ^a   Chowell, Gerardo ^b,c   Nishiura, Hiroshi ^d,e   Christensen, Ronald A ^a   McCullers, Jonathan A ^f  

^a Entropy Research Institute   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e UTRECHT UNIVERSITY   (Netherlands)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; CHILD; DISEASE PREDISPOSITION; GLYCOSYLATION; HUMAN; INCIDENCE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; SCHOOL CHILD; T LYMPHOCYTE; VIRUS STRAIN; EPIDEMIC; GENETICS; IMMUNOLOGY; INFLUENZA; MIDDLE AGED; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIGENS, VIRAL; CHILD; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; GLYCOSYLATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; YOUNG ADULT;

EID: 77149123171     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-5     Document Type: Article

References (44)

1. Mexico Ministry of Health Update on the S-OIV epidemic in Mexico (July 28rd, 2009). Mexico Ministry of Health., http://portal.salud.gob.mx/contenidos/noticias/influenza/estadisticas.html
2. Ontario Influenza Bulletin SURVEILLANCE WEEK 27 (July 5, 2009- July 11, 2009). Ministry of Health & Long-Term Care Public Health Division, Ontario Influenza Bulletin., http://www.health.gov.on.ca/english/providers/program/pubhealth/flu/flu_08/bulletins/flu_bul_01_20090711.pdf
3. ECDC Interim Risk Assessment Influenza A(H1N1) 2009 Pandemic. 2009, 5. ECDC., http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm
4. Situation of Influenza A(H1N1). Update No. 64. (07/14/2009). Ministerio de Salud de Argentina., http://municipios.msal.gov.ar/h1n1/2_situacion/situacion.php
5. Weekly Report of pandemic influenza A(H1N1). 07/29/09. Ministerio de Salud de Chile., http://www.minsal.cl/
6. Munayco CV, Gomez J, Laguna-Torres VA, Arrasco J, Garcia J, Kochel TJ, et al. Epidemiological and transmissibility analysis of the swine-origin A(H1N1) influenza pandemic in a Southern hemisphere setting: Peru. Euro Surveill 2009, 14(32). pii=19299., http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19299
7. Department of Health and Ageing (DHA), Australia Australian influenza report 2009 - Current report - 30 May to 16 June 2009. 2009, Canberra, DHA, Department of Health and Ageing (DHA), Australia., http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm
8. Environmental Science and Research (ESR), New Zealand Descriptive epidemiology of novel influenza A H1N1 New Zealand, April-June 2009 (Update 42). 2009, Porirua, ESR, Environmental Science and Research (ESR), New Zealand.
9. Nishiura H, Castillo-Chavez, Safan M, Chowell G. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill 2009, 14(22).
10. Ministry of Public Health (MOPH), Thailand Outbreaks of influenza A (H1N1). Situation updates (22 July 2009). 2009, Nonthhaburi, MOPH, Ministry of Public Health (MOPH), Thailand.
11. WHO Weekly Epidemiological Report. 2009, 84(21):185-90., http://www.who.int/wer/2009/wer8421/en/index.html
12. NIAID BioHealthBase BRC. , http://www.biohealthbase.org
13. Squires B, Macken C, Garcia-Sastre A, et al. BioHealthBase: informatics support in the elucidation of influenza virus host pathogen interactions and virulence. Nucleic Acids Research 2008, (36 Database):D497-503. 2238987, 17965094.
14. McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004, 78(23):12817-28. 10.1128/JVI.78.23.12817-12828.2004, 525012, 15542634.
15. Davenport FM, Hennesey AV, Francis T. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 1953, 99:641-656.
16. De St Groth F, Webster RG. Discussions of original antigenic sin: I. Evidence in man. J Exp Med 1966, 124(3):331-45. 10.1084/jem.124.3.331, 2138235, 5922742.
17. Katz J, et al. Serum cross-reactive antibody response to a novel influenza A(H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 2009, 58(10):1-4., http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5819a1.htm
18. Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998, 394(6692):482-5. 10.1038/28860, 9697771.
19. Scholtissek C, von Hoyningen V, Rott R. Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 1978, 89:613-7. 10.1016/0042-6822(78)90203-9, 716220.
20. Nakajima K, Desselberger U, Palese P. Recent human influenza A(H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 1978, 274:334-9. 10.1038/274334a0, 672956.
21. Brownlee GG, Fodor E. The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Phil Trans R Soc Lond B 2001, 356:1871-6.
22. Yu X, Tsibane T, McGraw PA, et al. Neutralizing antibodies derived from the B-cells of 1918 influenza pandemic survivors. Nature 2008, 455(7212):532-6. 10.1038/nature07231, 18716625.
23. Reichert TA, Christensen RA. It's not about smoldering or neuraminidase; There were two A(H3N2) pandemic internal gene variants. J Infect Dis 2005, 192:1858-60. 10.1086/497153, 16235189.
24. Kilbourne BD, Smith C, Brett I, Pokory BA, Johansson B, Cox N. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci USA 2002, 99:10748-52. 10.1073/pnas.162366899, 125033, 12136133.
25. Vigerust DJ, Ulet KB, Boyd KL, Madsen J, Hawgood S, McCullers JA. N-Linked Glycosylation Attenuates H3N2 Influenza Viruses. J Virol 2007, 81:8593-9. 10.1128/JVI.00769-07, 1951338, 17553891.
26. Reading PC, Morey LS, Crouch EC, Anders EM. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 1997, 71(11):8204-12. 192277, 9343171.
27. Gamblin SJ, Haire LF, Russell RJ, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 2004, 303:1838-42. 10.1126/science.1093155, 14764886.
28. Rimmelzwaan GF, Boon AC, Voeten JT, Berkhoff EG, Fouchier RA, Osterhaus AD. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotix T lymphocytes. Virus Res 2004, 103:97-100. 10.1016/j.virusres.2004.02.020, 15163496.
29. De Groot A, Ardito M, McClaine E, Moise L, Martin B. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A(H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009, 27:5740-5747. 10.1016/j.vaccine.2009.07.040, 19660593.
30. Greenbaum JA, Kotturi MF, Kim Y, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Nat Acad Sci USA 2009, 106:20365-70. 2777968,2777968, 19918065, 10.1073/pnas.0911580106.
31. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci USA 2004, 101(9):3166-71. 10.1073/pnas.0308391100, 365761, 14963236.
32. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025. 19672242.
33. Mauad T, Hajjar LA, Callegari GS, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Resp Crit Care 2010, 181:72-79.
34. Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1007(87):1944-50.
35. Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 2005, 162:686-93. 10.1093/aje/kwi257, 1266301, 16107568.
36. http://www.cdc.gov/flu/weekly/fluactivity.htm
37. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453:615-9. 10.1038/nature06945, 2441973, 18418375.
38. Aldridge JR, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci USA 2009, 106(13):5306-11. 10.1073/pnas.0900655106, 2664048, 19279209.
39. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, Miller MA. Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza. N Engl J Med 2009, 361:674-9. 10.1056/NEJMoa0904023, 19564633., http://content.nejm.org/cgi/content/full/NEJMoa0904023?resourcetype=HWCIT
40. Perez-Padilla R, Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-9. 10.1056/NEJMoa0904252, 19564631.
41. Fedson DS. Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza Other Respi Viruses 2009, 3(4):129-142. 10.1111/j.1750-2659.2009.00090.x, 19627370.
42. Zimmer SM, Burke DS. Historical Perspective - Emergence of Influenza A(H1N1) viruses. N Engl J Med 2009, 361:279-85. 10.1056/NEJMra0904322, 19564632.
43. Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H. Cross-subtypre protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis 1985, 151:81-8.
44. Francis T. On the doctrine of original antigenic sin. Proc Am Phil Soc 1960, 104:572-578.